Navigation Links
Focused Radiation Protects Tumor Patients' Brain Function
Date:10/5/2009

Researchers recommend standard treatment with monitoring over whole-brain radiotherapy

MONDAY, Oct. 5 (HealthDay News) -- Brain tumor patients experience more learning and memory problems when whole-brain radiation therapy (WBRT) is added to standard stereotactic radiosurgery (SRS), researchers have found.

SRS delivers narrowly focused beams of radiation to the tumor site.

The study included 58 patients with one to three newly diagnosed brain metastases who were randomly selected to receive SRS alone (30 patients) or SRS plus WBRT (28 patients). However, the trial was halted early because there was a 96 percent probability that patients in the SRS/WBRT group were significantly more likely to experience declines in memory and function after four months than those receiving SRS alone.

After four months, there were four deaths (13 percent) in the patients who received SRS alone and eight deaths (29 percent) in the SRS/WBRT group, the study authors reported. After one year, 73 percent of patients in the SRS/WBRT group were recurrence-free, compared with 27 percent of patients who received SRS alone.

Despite the better outcomes among patients in the SRS/WBRT group, the researchers advised against the use of WBRT because it causes a greater decline in brain function. When brain tumors recur, they can be managed effectively with surgery if they're spotted early through regular monitoring.

"Applicability of the findings is dependent on the willingness of patients and their physicians to adhere to a schedule of close monitoring, having consistent access to high-quality MRI, having access to a neurosurgical team willing and able to perform salvage resections when indicated, and applying strict physics quality-assurance procedures for SRS," wrote Dr. Eric L. Chang, of the University of Texas M.D. Anderson Cancer Center in Houston, and colleagues.

"This study provides level 1 evidence to support the use of SRS alone in the initial management of patients newly diagnosed with one to three brain metastases. We recommend that initial SRS alone combined with close clinical monitoring should be the preferred treatment strategy for such patients," they concluded.

The study appears online and in the November print issue of The Lancet Oncology.

More information

The U.S. National Cancer Institute has more about brain tumors.



-- Robert Preidt



SOURCE: The Lancet Oncology, news release, Oct. 4, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. President Clinton Hosts Special Session on Northern Ireland; Announces New Commitments Focused on Harnessing Innovation for Development
2. Focused Learning Environment Guides Student Success
3. Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses
4. Health2 Resources Announces News Portal, E-News Brief Focused on Patient Centered Medical Home
5. Kaiser Permanente Debuts New Ads Focused on Technology and Innovation
6. FertilityTies, Social Network for the Fertility-Focused Unveils New Site Design, Unique Features to Help Patients Find Fertility Doctors & More
7. Focused Health Solutions Selects Cardiocom Telehealth Technology to Support Early Intervention
8. Health Integrated Hosts Industry Collaborative Focused on the Patient-Centered Medical Home (PCMH)
9. Focused Health Solutions Partners With Emmi Solutions to Help Employers Achieve Greater Returns on Their Employee Health Care Investments
10. Expanding into New Markets with Customer-Focused Solutions, Orion Health Sees Strong Growth
11. Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... ... with HIV because it is not known to have significant interactions with antiretroviral ... to both lower cholesterol levels and dampen inflammation in the bloodstream. , While ...
(Date:4/24/2017)... ... 24, 2017 , ... Labs often perform the same operations ... operators and management to assess these processes with a critical eye—particularly in the ... , Created with the help of both internal and external process experts, ...
(Date:4/24/2017)... , ... April 24, 2017 , ... “Reflections of God’s ... God. “Reflections of God’s Work” is the creation of published author, Jerri Broglin, a ... comfort. , “I believe this a great eye-opener for those searching for answers, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
(Date:4/24/2017)... Spain (PRWEB) , ... April 24, 2017 , ... ... on the development of next generation neuro-thrombectomy systems for the treatment of Acute ... and manufacture its ANCD BRAIN device as the product advances towards regulatory and ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... announced that it will be participating in the Deutsche ... InterContinental Hotel in Boston, Massachusetts ... at 11:20 a.m. Eastern Time. A live ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  The ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
Breaking Medicine Technology: